John Dreixler is a biomedical researcher and studies biomarkers for different clinical studies, for example the role of Siglec 9 in Adult Respiratory Distress Syndrom (ARDS) as well as Activin A and aspirin in pre-eclamptic women and subsequent cardiac issues, at the University of Chicago.
“I want to help students and new alums navigate the sciences and academia, especially with necessity of post-graduate degrees for various employment possibilities.”
Graduation year: 1983
Post-grad: Doctor of biological sciences/neuroscience
Campus activities: Gamma Alpha Beta fraternity